Price T Rowe Associates Inc /Md/

13F Holdings History for Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

Symbol: BPMC
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.47M shares
Security Ownership: 2.3%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in Blueprint Medicines Corp Common Stock, par value $0.001 per share (BPMC)

2025-08-14 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.47M shares of Blueprint Medicines Corp Common Stock, par value $0.001 per share (BPMC). This represents 2.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
T. Rowe Price Associates, Inc.	2.3%		$188M	1.47M			$128.55	13G/A	6/30/2025	14 Aug 2025 13:07:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		-0.02%	$0	0	-1,464,968	-100%		Q3 2025
6/30/2025	0.02%	-0.06%	$188M	1.46M	-3,950,869	-73%	$128.18	Q2 2025
3/31/2025	0.06%	0%	$479M	5.42M	-263,252		$88.51	Q1 2025
12/31/2024	0.06%	+0%	$495M	5.68M	+291,822	+5.42%	$87.22	Q4 2024
9/30/2024	0.06%	-0.01%	$498M	5.39M	-486,125	-8.28%	$92.50	Q3 2024
6/30/2024	0.08%	0%	$633M	5.87M	-377,431	-6.04%	$107.78	Q2 2024
3/31/2024	0.07%	+0.01%	$593M	6.25M	+821,868	+15.1%	$94.86	Q1 2024
12/31/2023	0.07%	0%	$501M	5.43M	-67,622	-1.23%	$92.24	Q4 2023
9/30/2023	0.04%	0%	$276M	5.5M	-126,799	-2.25%	$50.22	Q3 2023
6/30/2023	0.05%	+0.01%	$355M	5.62M	+674,942	+13.6%	$63.20	Q2 2023
3/31/2023	0.03%	+0%	$223M	4.95M	+649,144	+15.1%	$44.99	Q1 2023
12/31/2022	0.03%	+0%	$188M	4.3M	+267,479	+6.63%	$43.81	Q4 2022
9/30/2022	0.04%	-0.02%	$266M	4.03M	-1,599,876	-28.4%	$65.89	Q3 2022
6/30/2022	0.04%	+0%	$284M	5.63M	+698,562	+14.2%	$50.51	Q2 2022
3/31/2022	0.03%	+0%	$315M	4.93M	+382,586	+8.41%	$63.88	Q1 2022
12/31/2021	0.04%	+0%	$487M	4.55M	+178,711	+4.09%	$107.11	Q4 2021
9/30/2021	0.04%	+0%	$449M	4.37M	+109,714	+2.57%	$102.81	Q3 2021
6/30/2021	0.03%	+0%	$375M	4.26M	+212,840	+5.26%	$87.96	Q2 2021
3/31/2021	0.04%	+0%	$394M	4.05M	+361,508	+9.8%	$97.23	Q1 2021
12/31/2020	0.04%	+0%	$414M	3.69M	+121,360	+3.4%	$112.15	Q4 2020
9/30/2020	0.04%	0%	$331M	3.57M	-23,478	-0.65%	$92.70	Q3 2020
6/30/2020	0.04%	+0%	$280M	3.59M	+3,793	+0.11%	$78.00	Q2 2020
3/31/2020	0.03%	+0%	$210M	3.59M	+232,524	+6.93%	$58.48	Q1 2020
12/31/2019	0.03%	0%	$269M	3.35M	-257,646	-7.13%	$80.11	Q4 2019
9/30/2019	0.04%	0%	$265M	3.61M	-70,078	-1.9%	$73.47	Q3 2019
6/30/2019	0.05%	+0%	$347M	3.68M	+305,682	+9.06%	$94.33	Q2 2019
3/31/2019	0.04%	+0%	$270M	3.38M	+353,502	+11.7%	$80.05	Q1 2019
12/31/2018	0.03%	+0%	$163M	3.02M	+137,760	+4.78%	$53.91	Q4 2018
9/30/2018	0.03%	0%	$225M	2.88M	-237,971	-7.62%	$78.06	Q3 2018
6/30/2018	0.03%	0%	$198M	3.12M	-346,249	-9.98%	$63.48	Q2 2018
3/31/2018	0.05%	+0%	$318M	3.47M	+159,165	+4.81%	$91.70	Q1 2018
12/31/2017	0.04%	+0.01%	$250M	3.31M	+562,244	+20.5%	$75.41	Q4 2017
9/30/2017	0.03%	+0%	$191M	2.75M	+273,173	+11%	$69.67	Q3 2017
6/30/2017	0.02%	+0%	$125M	2.47M	+459,336	+22.8%	$50.67	Q2 2017
3/31/2017	0.02%	+0.01%	$80.6M	2.01M	+1,275,147	+172%	$39.99	Q1 2017
12/31/2016	0%	+0%	$20.7M	740K	+386,308	+109%	$28.05	Q4 2016
9/30/2016	0%	0%	$10.5M	353K	-241,789	-40.6%	$29.70	Q3 2016
6/30/2016	0%	+0%	$12M	595K	+83,175	+16.3%	$20.25	Q2 2016
3/31/2016	0%	0%	$9.24M	512K	-22,040	-4.13%	$18.05	Q1 2016
12/31/2015	0%	+0%	$14.1M	534K	+35,699	+7.17%	$26.34	Q4 2015
9/30/2015	0%	0%	$10.6M	498K	-5,401	-1.07%	$21.34	Q3 2015
6/30/2015	0%	+0%	$13.3M	504K	+503,550	NEW	$26.49	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.